Speciality: Hematology
Description:
A warm welcome to all the medical professionals for The Conclusion of our "An Eagle's View" session on Iron Deficiency Anemia. We have taken an evidence-based approach to understanding IDA, and this concluding segment will synthesize our findings into actionable clinical takeaways. The key conclusion is that while oral iron remains a valid first-line option, a more patient-centric and proactive approach, heavily informed by recent data, is essential to close the care gap and improve patient outcomes.
The evidence points to a paradigm shift, where intravenous iron is no longer a last resort but a powerful and safe tool for rapid and effective iron repletion. Recent data support its use in specific patient populations, including those with severe anemia, a need for rapid correction, intolerance to oral iron, or co-morbidities like chronic heart failure and inflammatory bowel disease. This is crucial as a significant portion of patients do not achieve adequate iron repletion with oral supplements alone, leading to persistent symptoms and a reduced quality of life.
Therefore, the ultimate conclusion of this session is a call to action: to critically evaluate each patient's needs and consider the most effective and efficient treatment path from the outset. By integrating a deep understanding of the pros and cons of both oral and intravenous iron, medical professionals can empower themselves to make informed decisions that will directly and positively impact patient well-being. Continue to follow Hidoc for more such indispensable sessions that keep you at the forefront of medical advancements.
See More Webinars @ Hidoc Webinars
1.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
2.
These Athletes Weren't Doping. Their Genes Made It Look Like They Did.
3.
Understudied mental health challenges among caregivers of cancer patients: A call for targeted support
4.
Women are more susceptible to the stress caused by inflation.
5.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
1.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
2.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
3.
The Mystery of Carotid Body Tumors: The Facts You Need to Know
4.
Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology
5.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
5.
Understanding the causes of anemia in adults beyond nutritional deficiencies
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation